4.7 Article

Cross-seeding of prions by aggregated alpha-synuclein leads to transmissible spongiform encephalopathy

Journal

PLOS PATHOGENS
Volume 13, Issue 8, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1006563

Keywords

-

Funding

  1. National Institute of Health [NS045585]

Ask authors/readers for more resources

Aggregation of misfolded proteins or peptides is a common feature of neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, prion and other diseases. Recent years have witnessed a growing number of reports of overlap in neuropathological features that were once thought to be unique to only one neurodegenerative disorder. However, the origin for the overlap remains unclear. One possibility is that diseases with mixed brain pathologies might arise from cross-seeding of one amyloidogenic protein by aggregated states of unrelated proteins. In the current study we examined whether prion replication can be induced by cross-seeding by a-synuclein or A beta peptide. We found that alpha-synuclein aggregates formed in cultured cells or in vitro display cross-seeding activity and trigger misfolding of the prion protein (PrPC) in serial Protein Misfolding Cyclic Amplification reactions, producing self-replicating PrP states characterized by a short C-terminal proteinase K (PK)-resistant region referred to as PrPres. Non-fibrillar a-synuclein or fibrillar A beta failed to cross-seed misfolding of PrPC. Remarkably, PrPres triggered by aggregated alpha-synuclein in vitro propagated in animals and, upon serial transmission, produced PrPSc and clinical prion disease characterized by spongiosis and astrocytic gliosis. The current study demonstrates that aggregated a-synuclein is potent in cross-seeding of prion protein misfolding and aggregation in vitro, producing self-replicating states that can lead to transmissible prion diseases upon serial passaging in wild type animals. In summary, the current work documents direct cross-seeding between unrelated amyloidogenic proteins associated with different neurodegenerative diseases. This study suggests that early interaction between unrelated amyloidogenic proteins might underlie the etiology of mixed neurodegenerative proteinopathies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Sequestration of TDP-43216-414 Aggregates by Cytoplasmic Expression of the proSAAS Chaperone

Juan R. Peinado, Kriti Chaplot, Timothy S. Jarvela, Edward M. Barbieri, James Shorter, Iris Lindberg

Summary: As neurons age, protein homeostasis becomes less efficient, leading to misfolding and aggregation of proteins. Chaperone proteins play a vital role in maintaining cellular protein homeostasis and chaperone-based therapies may be useful in preventing the development of neurodegenerative diseases. In this study, the researchers found that proSAAS, a small secreted neuronal protein, can interact with protein aggregates in the cytoplasm and form liquid droplet-like spheres. These proSAAS spheres can encapsulate TDP-43 aggregates, and the interaction is driven by specific sequences in the proSAAS protein.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Clinical Neurology

The spectrum of disease and tau pathology of nodding syndrome in Uganda

Michael S. Pollanen, Sylvester Onzivua, Paul M. McKeever, Janice Robertson, Ian R. Mackenzie, Gabor G. Kovacs, Francis Olwa, David L. Kitara, Amanda Fong

Summary: This article describes the clinicopathologic spectrum of nodding syndrome in northern Uganda. All 16 cases had chronic seizures, and seven cases also had progressive cognitive, behavioural, and motor decline. The main neuropathologic findings included tau pathology, cerebellar degeneration, and white matter degeneration.

BRAIN (2023)

Review Clinical Neurology

Current Concepts of Mixed Pathologies in Neurodegenerative Diseases

Shelley L. Forrest, Gabor G. Kovacs

Summary: Neurodegenerative diseases are a group of disorders characterized by diverse pathology, clinical manifestations, and genetic variation. Mixed pathologies, including abnormal protein deposition, cerebrovascular disease, and aging-related pathologies, are commonly found in individuals with neurodegenerative diseases, and may lower the threshold for cognitive impairment and dementia. Understanding mixed pathologies can have implications for prognosis, biomarker development, therapy, and clinical trial design.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Article Endocrinology & Metabolism

The G209R Mutant Mouse as a Model for Human PCSK1 Polyendocrinopathy

Manita Shakya, Surbhi Gahlot, Nicolle K. Martin, Anoop Arunagiri, Martin G. Martin, Peter Arvan, Malcolm J. Low, Iris Lindberg

Summary: The G209R Pcsk1 mouse model generated using CRISPR/Cas9 technology replicates many of the neonatal deficiencies observed in humans with this homozygous mutation, showing a range of biochemical and tissue-level abnormalities associated with the mutation.

ENDOCRINOLOGY (2022)

Article Neurosciences

Detection of astrocytic tau pathology facilitates recognition of chronic traumatic encephalopathy neuropathologic change

Kamar E. Ameen-Ali, Abigail Bretzin, Edward B. Lee, Rebecca Folkerth, Lili-Naz Hazrati, Diego Iacono, C. Dirk Keene, Julia Kofler, Gabor G. Kovacs, Amber Nolan, Daniel P. Perl, David S. Priemer, Douglas H. Smith, Douglas J. Wiebe, William Stewart

Summary: This study evaluated the neuropathological changes of chronic traumatic encephalopathy (CTE) and found that the presence of both neuronal and astroglial tau pathologies facilitates the detection of CTE, while the detection is less consistent when only neuronal pathology is visible.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Clinical Neurology

Rainwater Charitable Foundation criteria for the neuropathologic diagnosis progressive supranuclear palsy

Shanu F. Roemer, Lea T. Grinberg, John F. Crary, William W. Seeley, Ann C. McKee, Gabor G. Kovacs, Thomas G. Beach, Charles Duyckaerts, Isidro A. Ferrer, Ellen Gelpi, Edward B. Lee, Tamas Revesz, Charles L. White, Mari Yoshida, Felipe L. Pereira, Kristen Whitney, Nikhil B. Ghayal, Dennis W. Dickson

Summary: The new neuropathologic criteria for diagnosing PSP showed high sensitivity and specificity, with almost perfect inter-rater reliability. Most cases had 100% agreement across all raters. The criteria feature a simplified diagnostic algorithm and incorporate tufted astrocytes as an essential diagnostic feature.

ACTA NEUROPATHOLOGICA (2022)

Article Clinical Neurology

Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer's disease

Yuanyuan Deng, Mian Bi, Fabien Delerue, Shelley L. Forrest, Gabriella Chan, Julia van der Hoven, Annika van Hummel, Astrid F. Feiten, Seojin Lee, Ivan Martinez-Valbuena, Tim Karl, Gabor G. Kovacs, Grant Morahan, Yazi D. Ke, Lars M. Ittner

Summary: In Alzheimer's disease, hyperexcitation of neuronal networks is an underlying disease mechanism. The study identifies LAMP5 as a novel regulator of hyperexcitation in mice, critical for the survival of distinct interneuron populations.

ACTA NEUROPATHOLOGICA (2022)

Article Clinical Neurology

Cell-Specific Dysregulation of Iron and Oxygen Homeostasis as a Novel Pathophysiology in PSP

Seojin Lee, Ivan Martinez-Valbuena, Carlos E. de Andrea, Maria Villalba-Esparza, Suganthini Ilaalagan, Blas Couto, Naomi P. Visanji, Anthony E. Lang, Gabor G. Kovacs

Summary: This study provides the first cell type-specific evaluation of iron homeostasis and oxygen homeostasis in relation to tau pathology in patients with progressive supranuclear palsy (PSP). Astrocytes were identified as the major cell type accumulating iron in the early affected regions of PSP, highly associated with tau pathology. Dysregulated expression of iron and oxygen homeostasis genes associated with brain aging was also found, as well as dysregulated expression of rare neurodegeneration with brain iron accumulation (NBIA) genes associated with tau pathology, distinguishing PSP from the healthy aging brain.

ANNALS OF NEUROLOGY (2023)

Article Clinical Neurology

The Rossy Progressive Supranuclear Palsy Centre: Creation and Initial Experience

Blas Couto, Susan Fox, Maria Carmela Tartaglia, Ekaterina Rogaeva, Jeffrey Antwi, Puja Bhakta, Gabor G. Kovacs, Anthony E. E. Lang

Summary: The study focuses on the development and initial experience of the Rossy PSP Centre in Canada, which aims to advance clinical and basic research in progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). The study collects extensive demographic and longitudinal clinical information using standardized forms, as well as biofluids for genetic analysis and neuroimaging research protocols. The preliminary results show a typical distribution of phenotypes, demographics, and response to symptomatic treatments in the cohort. Future steps include enrolling patients in earlier stages, developing biomarkers, and fast-tracking well-characterized patients into clinical trials.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Letter Clinical Neurology

Significant contralaterality of temporal-predominant neuroastroglial tauopathy and FTLD-TDP type C presenting with the right temporal variant FTD

Hidetomo Tanaka, Megan A. Hird, David F. Tang-Wai, Gabor G. Kovacs

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2023)

Article Clinical Neurology

Lack of difference between amyloid-beta burden at gyral crests and sulcal depths in diverse neurodegenerative diseases

Shojiro Ichimata, Ain Kim, Naoki Nishida, Gabor G. G. Kovacs

Summary: The aim of this study is to clarify whether there is a difference in amyloid-beta burden between gyral crests (GCs) and sulcal depths (SDs) in different neurodegenerative proteinopathies. The study found that amyloid-beta is almost evenly distributed in both GCs and SDs in the frontal and temporal lobes.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Clinical Neurology

Regional redistribution of CB1 cannabinoid receptors in human foetal brains with Down's syndrome and their functional modifications in Ts65Dn+/+ mice

Agoston Patthy, Janos Hanics, Gergely Zachar, Gabor G. Kovacs, Tibor Harkany, Alan Alpar

Summary: The expression and function of CB1R in the developing human brain, as well as in Down syndrome foetuses, were analyzed. The study found that CB1R expression was delayed in age-matched foetuses with Down syndrome, and abnormal CB1R signaling was identified. In vitro experiments showed that CB1R excitation led to excessive microtubule stabilization and reduced neurite outgrowth.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Clinical Neurology

Prevalence and Distribution of Lewy Pathology in a Homeless Population

Krisztina Danics, Naomi P. Visanji, Shojiro Ichimata, Sarika Mathur, Gabriella Sara-Klausz, Gabor G. Kovacs

Summary: This study investigates the prevalence and distribution of pathological alpha-synuclein deposition in the central and peripheral nervous systems of the homeless population. The findings suggest that alpha-synuclein pathology is prevalent in this vulnerable population, supporting the need for further research.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Article Biochemistry & Molecular Biology

Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer's Disease Associated with Down Syndrome

Shojiro Ichimata, Ivan Martinez-Valbuena, Seojin Lee, Jun Li, Ali M. Karakani, Gabor G. Kovacs

Summary: Limited comparative data exist on the molecular spectrum of amyloid-beta (Aβ) and tau deposition in individuals with Down syndrome (DS) and sporadic Alzheimer's disease (sAD). We found that DS cases had more severe Aβ and tau deposition in the temporal lobe and cerebellum compared to sAD cases, as confirmed by both semi-quantitative and quantitative analysis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Clinical Neurology

Regional redistribution of CB1 cannabinoid receptors in human foetal brains with Down's syndrome and their functional modifications in Ts65Dn+/+ mice

Agoston Patthy, Janos Hanics, Gergely Zachar, Gabor G. Kovacs, Tibor Harkany, Alan Alpar

Summary: The study revealed significant changes in CB1R expression in different brain regions during human embryonic development, as well as delayed CB1R development in individuals with Down syndrome. This delayed development may lead to impairments in brain neuroarchitecture, affecting neuronal development and synaptogenesis.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

No Data Available